Analysis published 23 Oct 2026

AI-generated · cited to primary sources · not investment advice

Berkshire Hathaway Inc. (BRK.A) Sep 2025 Filing Analysis

01 · Management Credibility

Does management do what it says?

Not yet dueOther Findings
73/100

The earlier remainder-of-2025 forecast can be reconciled to the first-half 2026 year-to-date forecast: the current filing reports $8.6 billion forecast for the remainder of 2026, down from $12.4 billion in the prior forecast, implying approximately $3.8 billion was spent in the first half of 2026 against the $12.4 billion remainder-of-2026 forecast. This does not provide evidence of the 2025 remainder spend. The commitment is therefore not verifiable from this document and is omitted from tracking. (1 met, 1 not yet due across 2 tracked commitments)

“BHE and BNSF forecast capital expenditures of approximately $4.4 billion over the remainder of 2025.”

Berkshire Hathaway Inc. Common Stock · Quarterly Report · Sep 2025 · p.51
In progressInsurance And Risk Transfer Free Cash Flow
60/100

At September 30, 2025, BNSF and BHE had spent a combined $10.124 billion in capital expenditures during the first nine months of 2025. The filing forecasts approximately $4.4 billion of combined BNSF and BHE capital expenditures over the remainder of 2025. This is a current-period forecast update, not evidence that the earlier $8.8 billion remainder-of-year forecast was achieved; the commitment is still active through year-end. (1 in progress across 1 tracked commitment)

“In the first nine months of 2025, our consolidated capital expenditures for property, plant and equipment and equipment held for lease were $14.7 billion, which included capital expenditures by BNSF and BHE of $10.1 billion. ... BHE and BNSF forecast capital expenditures of approximately $4.4 billion over the remainder of 2025.”

Berkshire Hathaway Inc. Common Stock · Quarterly Report · Sep 2025 · p.51
Insurance And Risk Transfer Policy and Regulation

Berkshire is evaluating the impact of the One Big Beautiful Bill Act on BHE's financial results and capital expenditures for renewable energy, storage, and technology-neutral projects; it has not quantified the impact.

“We are currently evaluating the potential implications of the OBBBA on BHE’s financial results and capital expenditures related to renewable energy, storage and technology neutral projects, including the potential impact on the economics and viability of such projects. These evaluations may be further affected by broader macroeconomic and geopolitical conditions, including changes in international trade policies and tariff regimes. Due to the inherent uncertainties involved, we are unable to estimate the impact on BHE’s energy business at this time.”

Berkshire Hathaway Inc. Common Stock · Quarterly Report · Sep 2025 · p.42

See the full cited Management analysis of Berkshire Hathaway Inc.

Create free account →
04 · Risk

What could break the thesis?

Insurance And Risk Transfer Supply Chain Reconfiguration

Management explicitly reported greater uncertainty around trade policies and tariffs during the first nine months of 2025 and said effects on product availability, supply-chain costs, efficiency, and demand could be adverse. The June 2026 baseline continues to identify these exposures without a comparable measure of worsening or improvement, so the risk is treated as stable. (1 stable, 1 insufficient_data)

“These events, including tensions from developing international trade policies and tariffs, accelerated through the first nine months of 2025. Considerable uncertainty remains as to the ultimate outcome of these events. We are currently unable to reliably predict the ultimate impact on our businesses, whether through changes in the availability of products, supply chain costs and efficiency, and customer demand...”

Berkshire Hathaway Inc. Common Stock · Quarterly Report · Sep 2025 · p.34

See the full cited Risk analysis of Berkshire Hathaway Inc.

Create free account →

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.